Literature DB >> 6147572

Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.

A Küpfer, B Schmid, R Preisig, G Pfaff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147572     DOI： 10.1016/s0140-6736(84)92591-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  Development of an ELISA to study the polymorphism of dextromethorphan oxidation in a French population.

Authors:  J P Frèche; S Dragacci; A M Petit; J P Siest; M M Galteau; G Siest
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Dextromethorphan phenotypes in paediatric patients with autoimmune hepatitis.

Authors:  E Jacqz-Aigrain; J Laurent; F Alvarez
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

3.  Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan.

Authors:  N E Basci; A Bozkurt; S O Kayaalp; A Sayal; A Isimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

4.  Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.

Authors:  O Mortimer; B Lindström; H Laurell; U Bergman; A Rane
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

5.  Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathy.

Authors:  L Belec; D Larrey; H De Cremoux; M Tinel; F Louarn; D Pessayre; R Gherardi
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

6.  Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.

Authors:  C Funck-Brentano; H K Kroemer; H Pavlou; R L Woosley; D M Roden
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

7.  Phenotypic differences in dextromethorphan metabolism.

Authors:  S J Vetticaden; B E Cabana; V K Prasad; E D Purich; J H Jonkman; R de Zeeuw; L Ball; L J Leeson; R L Braun
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

8.  Phenotyping polymorphic drug metabolism in the French Caucasian population.

Authors:  E Jacqz; H Dulac; H Mathieu
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 9.  Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.

Authors:  Bita Moghaddam; John H Krystal
Journal:  Schizophr Bull       Date:  2012-08-16       Impact factor: 9.306

10.  Cytochrome P-450IID6 phenotyping in cancer patients: debrisoquin and dextromethorphan as probes.

Authors:  L B Anthony; T J Boeve; K R Hande
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.